Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Linde

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Occupational and Environmental Hygiene|December 2, 2017
A retrospective analysis of nickel exposure data at a South African base metal refineryMonica M Young, Cornelius J Van Der Merwe, Stefan J L Linde, et al.
Public Health Action|December 2, 2024
Application of a TB care cascade to a novel household contact intervention in rural South AfricaL Linde, L B van Niekerk, K W le Roux, et al.
Elife|October 7, 2020
A versatile system to record cell-cell interactionsRui Tang, Christopher W Murray, Ian L Linde, et al.
Nature|April 30, 2015
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunityYaron Carmi, Matthew H Spitzer, Ian L Linde, et al.
Revista Espanola De Cardiologia|May 2, 2009
Comparison of medium-term outcomes obtained with drug-eluting stents and coronary artery bypass grafts in an unselected population of diabetic patients with multivessel coronary disease. Propensity score analysisAntonio J Domínguez-Franco, Manuel F Jiménez-Navarro, José M Hernández-García, et al.
JCI Insight|November 5, 2016
Akt and SHP-1 are DC-intrinsic checkpoints for tumor immunityYaron Carmi, Tyler R Prestwood, Matthew H Spitzer, et al.
Cancer Research|March 5, 2020
Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer ImmunotherapyNadine Santana-Magal, Leen Farhat-Younis, Amit Gutwillig, et al.
Cancer Cell|January 27, 2023
Neutrophil-activating therapy for the treatment of cancerIan L Linde, Tyler R Prestwood, Jingtao Qiu, et al.
Cancer Cell|January 9, 2024
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapiesErica T Goddard, Miles H Linde, Shivani Srivastava, et al.
Cancer Discovery|March 1, 2023
Reprogramming Cancer into Antigen-Presenting Cells as a Novel ImmunotherapyMiles H Linde, Amy C Fan, Thomas Köhnke, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Occupational and Environmental Hygiene|December 2, 2017
A retrospective analysis of nickel exposure data at a South African base metal refineryMonica M Young, Cornelius J Van Der Merwe, Stefan J L Linde, et al.
Public Health Action|December 2, 2024
Application of a TB care cascade to a novel household contact intervention in rural South AfricaL Linde, L B van Niekerk, K W le Roux, et al.
Elife|October 7, 2020
A versatile system to record cell-cell interactionsRui Tang, Christopher W Murray, Ian L Linde, et al.
Nature|April 30, 2015
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunityYaron Carmi, Matthew H Spitzer, Ian L Linde, et al.
Revista Espanola De Cardiologia|May 2, 2009
Comparison of medium-term outcomes obtained with drug-eluting stents and coronary artery bypass grafts in an unselected population of diabetic patients with multivessel coronary disease. Propensity score analysisAntonio J Domínguez-Franco, Manuel F Jiménez-Navarro, José M Hernández-García, et al.
JCI Insight|November 5, 2016
Akt and SHP-1 are DC-intrinsic checkpoints for tumor immunityYaron Carmi, Tyler R Prestwood, Matthew H Spitzer, et al.
Cancer Research|March 5, 2020
Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer ImmunotherapyNadine Santana-Magal, Leen Farhat-Younis, Amit Gutwillig, et al.
Cancer Cell|January 27, 2023
Neutrophil-activating therapy for the treatment of cancerIan L Linde, Tyler R Prestwood, Jingtao Qiu, et al.
Cancer Cell|January 9, 2024
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapiesErica T Goddard, Miles H Linde, Shivani Srivastava, et al.
Cancer Discovery|March 1, 2023
Reprogramming Cancer into Antigen-Presenting Cells as a Novel ImmunotherapyMiles H Linde, Amy C Fan, Thomas Köhnke, et al.
Pageof 4